Fig 2.

Distribution of eGFR according to mGFR in development cohort and external validation cohorts. eGFR was calculated with the kidney recipient specific GFR equation on the basis of recipient creatinine level, age, and sex. P₃₀ is the proportion of eGFR within 30% of mGFR. Correct classification is the agreement between eGFR and mGFR according to GFR stages. ABCAN=Angiotensin II Blockade for Chronic Allograft Nephropathy; BENEFIT=Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial; BENEFIT-EXT=Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial-EXTended criteria donors; CKD-EPI=Chronic Kidney Disease Epidemiology Collaboration; GFR=glomerular filtration rate; eGFR=estimated glomerular filtration rate; KRS=kidney recipient specific; mGFR=measured glomerular filtration rate